Uranium Royalty announces $30M bought deal financing

Uranium Royalty entered into an agreement with a syndicate of underwriters, led by BMO Capital Markets as sole bookrunner, under which the underwriters have agreed to purchase, on a bought deal basis, 10,205,000 common shares at a price of U.S.$2.94, for gross proceeds of approximately $30 million. The Company has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any. The Offering is expected to close on or about October 17, 2023 and is subject to the Company receiving all necessary regulatory approvals. The Company currently intends to use the net proceeds of the Offering primarily to fund future purchases of physical uranium, implement its growth strategy through future acquisitions of royalties, streams, physical uranium and similar interests, and for other general working capital purposes.